Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stanley Lapidus Insider Profile
4 Followers
Stanley Lapidus, Director at T2 Biosystems, holds 101.59K shares in Lucid Diagnostics (Ticker: LUCD), holds 53.01K shares in T2 Biosystems (Ticker: TTOO).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+117.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stanley Lapidus holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stanley Lapidus
Stanley Lapidus's Trading History
T2 Biosystems
Jun 13, 2019
Director
Uninformative Sell
12.96K
$197.20K
Lucid Diagnostics
Sep 27, 2023
Director
Uninformative Sell
43.42K
$94.38K
List of latest transactions for each holding click on a transaction to see Stanley Lapidus's performance on stock
You May Also Like
Stanley Lapidus insider profile FAQ
What is the percentage of profitable transactions made by Stanley Lapidus?
The percentage of profitable transactions made by Stanley Lapidus is 100%.
What is the average return per transaction made by Stanley Lapidus?
The average return per transaction made by Stanley Lapidus is 117.20%.
What stocks does Stanley Lapidus hold?
Stanley Lapidus holds: TTOO, LUCD stocks.
What was Stanley Lapidus’s latest transaction?
Stanley Lapidus latest transaction was an Uninformative Sell of $43.42K.
What was Stanley Lapidus's most profitable transaction?
Stanley Lapidus’s most profitable transaction was an Informative Buy of TTOO stock on June 8, 2017. The return on the trade was 153.60%.
What is Stanley Lapidus's role in T2 Biosystems?
Stanley Lapidus's role in T2 Biosystems is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.